Characteristics, Treatment Patterns and Retention with Extended-Release Subcutaneous Buprenorphine for Opioid Use Disorder: A Population-Based Cohort Study in Ontario, Canada.Created by Anita Iacono, Tianru Wang, Mina Tadrous, Tonya Campbell, Gillian Kolla, Pamela Leece, Beth Sproule, Robert Kleinman…Uptake and retention for opioid agonist treatment (OAT) remains low. Novel extended-release formulations may improve OAT accessibility by reducing the frequency of healthcare visits. Our aim was to examine uptake, characteristics, treatment patterns and retention of individuals… |
https://www.cmaj.ca/content/196/2/E53 |
Conducting collaborative research locally, nationally and globally.
General
Content
Integrations